Neurodegenerative diseases

  • Email
  • Help

This page brings together the Agency's latest information on diseases causing problems with the brain and nervous system, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. It lists:

the ten newest and recently updated medicines authorised for the treatment of neurodegenerative diseases in the European Union (EU);

the most recent opinions on medicines for neurodegenerative diseases that are pending authorisation by the European Commission (EC);

the latest news and press releases related to neurodegenerative diseases;

the Agency's events on topics related to neurodegenerative diseases.

New and recently updated medicines

Opinions pending EC decision



  • 11/11/2016


    Spinal muscular atrophy workshop

    The European Medicines Agency (EMA), SMA Europe and TREAT NMD are co-organising a one-day workshop on spinal muscular atrophy (SMA) on 11th November this year. The workshop will bring together key stakeholders to discuss, help and advance the development of therapies for the treatment of SMA. Topics for discussion will include an overview of the disease, the pharmacology of the molecules under investigation, natural history data, clinical outcome measures and biomarkers. ... Read more